Bovine colostrum (generic name)
- Auto Immune Conditions
- Bladder & Kidney Health
- Brain & Nervous System
- Care Transitions
- Dental Health
- Emotional Health
- Eye Health
- Falls Prevention
- Financial Planning
- General Safety
- Health Care Basics
- Healthy Living
- Hearing Loss
- Heart Health
- High Blood Pressure
- Life Transitions
- Lung Health
- Men's Health
- Nutrition & Weight Management
- Pain Management
- Preventive Health
- Sexual Health
- Stomach & Digestive Health
- Stress & Anxiety
- Women's Health
This information is based on a systematic review of scientific literature, and was peer-reviewed and edited by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Rebecca Bramwell, PharmD (Northeastern University); J. Kathryn Bryan, BA (Natural Standard Research Collaboration); Ashley Brigham, PharmD (Northeastern University); Craig Coffenberg, PharmD (University of Rhode Island); Julie Conquer, PhD (RB Consulting); Nicole Giese, MS (Natural Standard Research Collaboration); Julie Goodfriend, PharmD (Northeastern University); Son Le, PharmD (Massachusetts College of Pharmacy); Jason Mahoney, BA (Natural Standard Research Collaboration); Julie Montalbano, PharmD (Massachusetts College of Pharmacy); Audrey Nealon, PharmD (Northeastern University); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Heeja Yoon, PharmD (Drake University).
BibliographyDISCLAIMER: Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.
Ashraf H, Mahalanabis D, Mitra AK, et al. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial. Acta Paediatr. 2001;90(12):1373-1378.
Bolke E, Orth K, Jehle PM, et al. Enteral application of an immunoglobulin-enriched colostrum milk preparation for reducing endotoxin translocation and acute phase response in patients undergoing coronary bypass surgery--a randomized placebo-controlled pilot trial. Wien.Klin Wochenschr. 11-30-2002;114(21-22):923-928.
Casswall TH, Sarker SA, Faruque SM, et al. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial. Scand.J.Gastroenterol. 2000;35(7):711-718.
Crooks CV, Wall CR, Cross ML, et al. The effect of bovine colostrum supplementation on salivary IgA in distance runners. Int J Sport Nutr Exerc.Metab 2006;16(1):47-64.
Lindbaek M, Francis N, Cannings-John R, et al. Clinical course of suspected viral sore throat in young adults: cohort study. Scand J Prim.Health Care 2006;24(2):93-97.
Mero A, Nykanen T, Keinanen O, et al. Protein metabolism and strength performance after bovine colostrum supplementation. Amino.Acids 2005;28(3):327-335.
Nakajima K, Kinoshita M, Matsushita N, et al. Capillary affinity electrophoresis using lectins for the analysis of milk oligosaccharide structure and its application to bovine colostrum oligosaccharides. Anal.Biochem 1-1-2006;348(1):105-114.
Niklowitz P, Menke T, Giffei J, et al. Coenzyme Q10 in maternal plasma and milk throughout early lactation. Biofactors 2005;25(1-4):67-72.
Paddle, B. M., Wong, V. K., and Muller, B. D. The cytotoxic effect of anthrax lethal toxin on human lung cells in vitro and the protective action of bovine antibodies to PA and LF. J Appl Toxicol 2006;26(2):162-168.
Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 4-24-2004;363(9418):1346-1353.
Rollison DE, Newschaffer CJ, Tao Y, et al. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Cancer 3-1-2006;118(5):1279-1284.
Schernhammer ES, Holly JM, Hunter DJ, et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr.Relat Cancer 2006;13(2):583-592.
Schoen RE, Weissfeld JL, Kuller LH, et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005;129(2):464-475.
Severi G, Morris HA, MacInnis RJ, et al. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol.Biomarkers Prev. 2006;15(6):1137-1141.
Shi R, Berkel HJ, Yu H. Insulin-like growth factor-I and prostate cancer: a meta-analysis. Br J Cancer 9-28-2001;85(7):991-996.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.